Nazia Khan

Navigating Nasdaq And NYSE: Essential Insights For Companies

Revised Schedule 13g Filing Deadlines Effective As Of September 30, 2024 – What You Need To Know

Reclassifying Cannabis As A Schedule III Substance – Will The DEA Agree?

SEC Adopts Amendments Regarding Insider Trading Plans And Related Disclosures

SEC Releases Pay Versus Performance Disclosure Requirements For Public Companies

SEC Proposes Amendments To Schedule 13 Beneficial Ownership Reporting Requirements

FDA Commissioner Signals Enforcement Policy, Advancement Of Research For CBD Products

SEC Administrative Proceedings Against Public Companies For Failure To Remediate Material Weaknesses In Internal Control Over Financial Reporting

Expansion Of Regulation A To Reporting Companies: Increased Alternatives Now Available To Public Companies Seeking To Raise Capital Or For Mergers And Acquisitions

The Effects Of The SEC Shutdown On The Capital Markets